Oncodesign Sa operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Oncodesign Sa with three other
companies in this sector in France:
sales of 18.19 million Euro [US$20.12 million]
of which 98%
Ose Immunotherapeutics SA
(24.46 million Euro [US$27.05 million]
(25.45 million Euro [US$28.16 million]
During the year ended December of 2018, sales at
Oncodesign Sa were 20.09 million Euro (US$22.22 million).
increase of 40.4%
versus 2017, when the company's sales were 14.31 million Euro.